IDT Australia eyes strongest session in over four years as EBITDA loss narrows
** Shares of IDT Australia IDT.AX rise 22.1% to A$0.0525, on track for strongest session since Nov 2021 if gains hold ** Stock hits highest level since Jan 5 ** Pharma co's HY EBITDA loss narrows to A$0.4 million, compared to A$2.7 million last year ** About 679,966 shares change hands, 3.2x the 30-day average of 214,882 ** Stock up 2.9% YTD including moves in current session (Reporting by Jasmeen Ara Shaikh in Bengaluru) ((Jasmeenaraislam.Shaikh@thomsonreuters.com;))
Recent news on IDT Australia
See all newsBrief: IDT Australia Sees Unaudited Fy26 Revenue From Three Verticals To Rise To A$16.8 Million
IDT Australia soars on upgraded annual earnings forecasts
IDT Australia climbs on positive FY26 outlook
Brief: Idt Australia Forecasts FY26 EBITDA Loss Of A$1.5m-A$2m
IDT Australia eyes strongest session in over four years as EBITDA loss narrows